Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Expression Profiling of Inflammatory Breast Cancer Cells Treated with the Novel Histone Deacetylase Inhibitor, CG-1521

ABSTRACT: Studies of gene expression profiles using the whole genome wide microarray analysis in SUM149PT cells (ER-, p53mut) and SUM190PT cells (ER-, p53mut) when treated with 5 or 7.5 uM CG-1521 alone and in combination with 10 nM 17beta-estradiol. Comparisons between each treatment group provides evidence for the dysregulation of genes associated with the spindle assembly checkpoint. Three independent experiments were carried out in SUM149PT and SUM190PT cells, which were treated with vehicle (ethanol/DMSO), 10nM 17beta-estradiol, 5 or 7.5 uM CG-1521, and the combination of 17 beta-estradiol and CG-1521. Total RNA was extracted from cell lysates using QIAGEN RNeasy mini kit after 48h of treatment.

ORGANISM(S): Homo sapiens

SUBMITTER: Sridar Chittur 

PROVIDER: E-GEOD-28542 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Json Xml
altmetric image

Publications

Histone deacetylase inhibitors modulate miRNA and mRNA expression, block metaphase, and induce apoptosis in inflammatory breast cancer cells.

Chatterjee Namita N   Wang Wei-Lin Winnie WL   Conklin Tucker T   Chittur Sridar S   Tenniswood Martin M  

Cancer biology & therapy 20130624 7

To develop new therapies for inflammatory breast cancer (IBC) we have compared the effects of two hydroxamic acid-based histone deacetylase (HDAC) inhibitors, CG-1521 and Trichostatin A (TSA) on the biology of two IBC cell lines: SUM149PT and SUM190PT. CG-1521 and TSA induce dose (0-10 µM) and time-dependent (0-96 h) increases in the proportion of cells undergoing cell cycle arrest and apoptosis in the presence or absence of 17β-estradiol. In SUM 149PT cells, both CG-1521 and TSA increase the le  ...[more]

Similar Datasets

Transcriptomics Expression Profiling of Inflammatory Breast Cancer Cells Treated with the Novel Histone Deacetylase Inhibitor, CG-1521 (Agilent miRNA v12.0)
2011-04-12 | E-GEOD-28543 | biostudies-arrayexpress
Transcriptomics Expression Profiling of Inflammatory Breast Cancer Cells Treated with the Novel Histone Deacetylase Inhibitor, CG-1521
2011-04-12 | E-GEOD-28544 | biostudies-arrayexpress
Unknown Expression Profiling of Inflammatory Breast Cancer Cells Treated with the Novel Histone Deacetylase Inhibitor, CG-1521 (Affymetrix HuGene-1_0)
2011-04-12 | GSE28542 | GEO
Unknown Expression Profiling of Inflammatory Breast Cancer Cells Treated with the Novel Histone Deacetylase Inhibitor, CG-1521 (Agilent miRNA v12.0)
2011-04-12 | GSE28543 | GEO
Transcriptomics 7.5uM CG-1521 and 5uM TSA treatment of LNCaP Prostate Cancer cells
2007-09-15 | E-GEOD-8645 | biostudies-arrayexpress
Unknown 7.5uM CG-1521 and 5uM TSA treatment of LNCaP Prostate Cancer cells
2007-09-15 | GSE8645 | GEO
Transcriptomics Gene expression analysis of S. cerevisiae treated with the histone deacetylase inhibitor CG-1521
2014-06-02 | E-GEOD-54300 | biostudies-arrayexpress
Unknown Gene expression analysis of S. cerevisiae treated with the histone deacetylase inhibitor CG-1521
2014-06-02 | GSE54300 | GEO
Transcriptomics Isolation of subtype-specific N-Ras responsive genes in basal-like breast cancer cells
2015-06-06 | E-GEOD-61768 | biostudies-arrayexpress
Unknown Genome-wide analysis of ERalpha binding sites in U2OS-ERalpha cells
2011-05-03 | GSE28918 | GEO